Infusion Billing Fraud: Administration Time Is Not Drug Quantity

Physician infusion administration billing fraud misrepresents the service of giving a drug, including its duration, supervision or an extra visit billed alongside it. The infusion record may show when treatment started and stopped, while the drug claim says how much medication the practice supplied. Those are different claims about the same patient encounter. If you are the nurse who administered the treatment, the physician whose billing number appears on it or the biller who entered the charges, you may know exactly where the claim stopped describing the care.

In a buy-and-bill practice, the business purchases medication, holds inventory, administers the drug and bills for the drug and its administration. A physician billing fraud case can turn on what happened between those steps. The medication, the administration service and a separately charged evaluation and management visit each need their own support.

What the Administration Claim Actually Measures

An administration claim describes the work of delivering treatment. Medicare separates hydration, therapeutic or diagnostic injections and infusions, and chemotherapy administration. Within those categories, the initial service, subsequent work, concurrent administration and additional time have different payment rules.

For physician billing, the Medicare Claims Processing Manual selects the initial service by the main reason for the encounter, regardless of which drug goes first. Ordinarily, there is one initial service per encounter. The exceptions are two separate IV sites required by protocol or a return visit for a separately identifiable service that day.

The administration hierarchy follows what actually happened. A subsequent push follows an earlier service. A sequential infusion delivers another drug after the first finishes. Concurrent administration happens at the same time. The physician billing rules allow one concurrent infusion service per encounter. The order, administration record and access-site documentation explain which relationship the claim describes.

Time-based add-on charges also have a threshold. The manual allows an additional-hour infusion code only when the interval exceeds 30 minutes beyond the hour increment. It defines an IV push as an injection with the professional continuously present to administer and observe, or an infusion lasting 15 minutes or less. The elapsed administration time matters to that choice. The patient’s whole appointment is a different measure.

The Supplies Already in the Administration Payment

Medicare includes the IV start, access to an existing catheter or port, and concluding flush in the administration payment. Chemotherapy administration also includes preparation of the chemotherapy agent. An insider who sees these items separated into extra charges is looking at work the administration payment already covers.

The national coding policy also treats fluid used to carry a drug or keep the line open as incidental hydration. Hydration concurrent with other drug administration is not separately payable. A separate hydration charge needs the clinical work behind it, rather than just the presence of fluid in the line.

Why Start and Stop Times Cannot Prove the Dose

Infusion start and stop times describe duration, but not administered milligrams. A purchase invoice describes medication acquired, but not how long the infusion ran. Both records become useful when they connect to the order, the administration record and the submitted claim.

This distinction matters when one part of the chart looks convincing. A timed nursing entry still leaves the drug identity, ordered dose, delivered amount and billed units to be reconciled. A drug purchase still leaves the patient’s treatment to be established. We follow the medication from acquisition through administration and waste, then compare that account with what the government paid for.

For separately payable Medicare Part B drugs from single-dose containers, the Centers for Medicare & Medicaid Services’ discarded-drug guidance separates the administered amount from eligible discarded amounts. JW identifies the discarded units on a separate claim line. JZ attests to no discarded amount eligible for separate payment. The order, vial size, administered dose, discard record and billing unit therefore belong together. An infusion clock cannot answer where the contents of the vial went.

When a Same-Day Office Visit Is Separate

A same-day evaluation and management claim alongside an infusion requires a significant, separately identifiable service. Medicare’s administration payment already includes the work and practice expense of the lowest-level established-patient office visit, code 99211. Other eligible office E/M services may be billed with modifier 25 when the separate work occurred.

The question behind an extra visit billed with modifier 25 is what the physician actually evaluated or managed beyond the administration service. A different diagnosis is not required. A separate service is. The note needs to describe that work, and the claim needs to match it.

This is where the nurse’s account and the physician’s signed note can become consequential. If the nurse provided the infusion and the chart also describes a physician visit, the schedule, progress note and billing record should account for both. Hudson Valley Hematology-Oncology Associates’ case shows what happens when the extra visit exists in the claim but lacks the documented work behind it.

When the Physician’s Name Does Not Describe the Work

Incident-to billing depends on the actual treatment and supervision, including the initial physician service and continuing involvement in the course of care. Employment by the practice, physician ownership or a later signature does not supply those facts. The useful comparison is among the treating worker, supervising practitioner, treatment plan, service date and billing identity.

Direct nurse-practitioner claims generally have an allowance of 85% of the physician fee schedule amount. Qualifying physician-supervised incident-to claims may use the physician allowance, which gives a practice a financial reason to put the physician’s number on the claim.

The date matters because supervision rules have changed. Under the 2026 Medicare physician fee schedule rule, applicable incident-to services can receive direct supervision through real-time audio and video, excluding audio-only. We examine how supervision occurred under the rule for the service date, alongside the other incident-to requirements.

Infusion4Health illustrates the billing-identity problem. In its 2020 enforcement announcement, the Department of Health and Human Services’ Office of Inspector General alleged that the California company billed services performed by employed nurse practitioners as if a physician had provided them, without the appropriate physician supervision. The company agreed to a civil payment over allegations involving infusions, injections, hydration and office visits.

Hudson Valley’s Schedule, Signature and Extra Visit

Hudson Valley agreed to pay $5,314,000 under its court-approved settlement. The practice admitted overbilling Medicare and Medicaid for E/M services alongside chemotherapy, injections or blood draws without documenting significant, separately identifiable E/M work. It also admitted billing E/M services without documenting that they were medically necessary or actually performed. The settlement also covered copayment billing.

The case began with a whistleblower who had worked in accounts receivable, coding and charge entry. The Justice Department joined the case and settled with the practice, crediting the inspector general’s investigative work. Someone who knew how charges entered the system supplied a view that the paid claim alone could not provide.

The government’s complaint alleged that Hudson Valley maintained separate physician and nursing schedules. Patients on the nursing schedule typically received services such as injections, blood draws or chemotherapy without seeing a doctor. At day’s end, the complaint alleged, nonphysician practitioners left those charts for a physician to sign, certifying participation in the patients’ evaluation and management.

The complaint described what the physician filled in:

The government tied that alleged practice to additional E/M charges. In an anemia-infusion example, it alleged that the nursing notes described the usual infusion while the chart certified physician evaluation and management and the practice billed an extra visit. In the government’s account, Medicare was billed for a doctor’s visit the patient never received. We see a signature doing the job of a visit.

For an infusion insider, the case connects a staffing record to a chart entry and then to government money. A nurse can explain the care delivered. A charge-entry employee can explain how the additional visit reached the claim. The record comparison gives each person’s knowledge a place in the same account.

Drug and Time Records Can Be False Together

A criminal plea involving an Anchorage rheumatologist shows why quantity and time deserve separate scrutiny. In her plea agreement, the physician admitted billing for prescribed medication while giving patients smaller doses, free samples, expired drugs or medication bought by other patients. She also admitted false statements in medical records about the identity and quantity of injected substances.

The same criminal plea describes false records of time spent treating patients and claims for prolonged services that were not provided. These were injection and prolonged-service admissions, with distinct false statements about medication and professional time. The parallel for an infusion practice is the need to establish both: what reached the patient and what service the claim says accompanied it.

What Evidence Does a Whistleblower Need?

An infusion whistleblower’s evidence connects the submitted claim with the actual treatment and the people who controlled the billing. We work with you to connect what you saw to records such as the administration chart, nursing schedule and drug inventory. Instructions about charges, code changes and responses to warnings can show how a discrepancy became a repeated claim.

Claims comparisons can point to the encounters worth examining. The administration record and firsthand witness account then explain what happened at those encounters.

A 2017 Journal of AHIMA article, Busting Bad Medicine: a Call to Action Addressing Healthcare, Fraud, Waste, and Abuse, explains why the person behind the records matters:

For this kind of health care case, your knowledge can explain who entered the time, who administered the drug and who directed the extra charge. We connect that knowledge to the clinical and billing records in evaluating a physician practice qui tam case. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When You Know What Happened in the Infusion Chair

If you know the treatment delivered and the claim tell different stories, speak with our whistleblower experts about the infusion billing. We work beside you to build the case around the drug, the administration and the decisions that changed the bill, and bring in healthcare fraud whistleblower lawyers who understand physician-practice payment. Your knowledge of what happened in that room is where our work together begins.